UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049159
Receipt number R000055853
Scientific Title Research on the effectiveness of S-LEC Solar Control Film L, a heat insulation interlayer film for laminated glass, in reducing thermal sensation induced mainly by near-infrared rays.
Date of disclosure of the study information 2022/10/07
Last modified on 2024/04/01 14:39:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the effectiveness of S-LEC Solar Control Film L, a heat insulation interlayer film for laminated glass, in reducing thermal sensation induced mainly by near-infrared rays.

Acronym

Research on the effectiveness of S-LEC Solar Control Film L, a heat insulation interlayer film for laminated glass, in reducing thermal sensation induced mainly by near-infrared rays.

Scientific Title

Research on the effectiveness of S-LEC Solar Control Film L, a heat insulation interlayer film for laminated glass, in reducing thermal sensation induced mainly by near-infrared rays.

Scientific Title:Acronym

Research on the effectiveness of S-LEC Solar Control Film L, a heat insulation interlayer film for laminated glass, in reducing thermal sensation induced mainly by near-infrared rays.

Region

Japan


Condition

Condition

Adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effectiveness of S-LEC Solar Control Film L, a heat insulation interlayer film for laminated glass, in reducing thermal sensation (burning sensation) induced mainly by near-infrared rays.

Basic objectives2

Others

Basic objectives -Others

Not applicable.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Time to feel heat sensation (burning sensation)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Near-infrared radiation is irradiated to the dorsal surface of the right hand using test sample 1.

Interventions/Control_2

Near-infrared radiation is irradiated to the dorsal surface of the right hand using test sample 2.

Interventions/Control_3

Near-infrared radiation is irradiated to the dorsal surface of the right hand using test sample 3.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Healthy Japanese male and female 18 years or older on the day consent is obtained.
2) Those who understand the research and have given written consent based on their free will.
3)Those who can fill out the consent form, questions, and other documents based on their understanding of the study.
4) Those who can come to the designated facility on the day of the research.

Key exclusion criteria

1) Those with dermatitis, bruises, trauma, or other conditions on the hands and forearms that make them unsuitable for testing.
2) Those whose left and right hands and forearms differ in pain or heat sensitivity.
3) Those with photosensitivity or a history of photosensitivity.
4) Those with subjective symptoms such as heat in the hands and forearms.
5) Those who have perceptual abnormalities, such as hypoesthesia.
6) Those with excessive sunburn.
7) Those receiving medication for pain.
8) Those with a history or complications that may affect the evaluation of this study.
9) Who are participating in other clinical research or clinical trials.
10) Those who are deemed inappropriate by the principal investigator.

Target sample size

36


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Kawashima

Organization

Non-Profit Organization Health Institute
Research of Skin

Division name

Vice Chairman

Zip code

101-0047

Address

Fukuda Building 2F,1-8-9 Uchikanda, Chiyoda-ku, Tokyo

TEL

03-3256-2575

Email

info@npo-hifu.net


Public contact

Name of contact person

1st name Akira
Middle name
Last name Nomachi

Organization

EBC&M LLC.

Division name

Project planning and Development department

Zip code

105-0011

Address

Shiba Matsuo Building 4F, 2-9-1 Shibakoen, Minato-ku, Tokyo

TEL

03-6435-3833

Homepage URL


Email

akira_nomachi@ebc-m.com


Sponsor or person

Institute

Non-Profit Organization Health Institute Research of Skin

Institute

Department

Personal name



Funding Source

Organization

SEKISUI CHEMICAL CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Non-Profit Organization Health Institute
Research of Skin

Name of secondary funder(s)



IRB Contact (For public release)

Organization

clinical research review board of the NPO Health Institute research of skin

Address

Fukuda Building 2F,1-8-9 Uchikanda, Chiyoda-ku, Tokyo

Tel

03-3256-2575

Email

info@npo-hifu.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社ビューティアンドヘルスリサーチ


Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 07 Day


Related information

URL releasing protocol

https://onlinelibrary.wiley.com/doi/epdf/10.1111/jocd.15876

Publication of results

Published


Result

URL related to results and publications

https://onlinelibrary.wiley.com/doi/epdf/10.1111/jocd.15876

Number of participants that the trial has enrolled

49

Results

Results: Laminated glass with S-LEC Solar Control Film L reduced the burning sensation caused by NIR and delayed the onset of the sensation, compared with the control glasses.
Conclusion: The use of S-LEC Solar Control Film L in the laminated glass of vehicles may improve passenger comfort and prevent skin disorders such as photoaging caused by prolonged exposure to NIR.

Results date posted

2024 Year 04 Month 01 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2023 Year 09 Month 01 Day

Baseline Characteristics

A total of 49 subjects provided informed consent to participate in the study, and included 22 males and 27 females with a mean age of 43.6 and 41.4 years, respectively.

Participant flow

All 49 participants were included in the analysis.

Adverse events

No adverse events related to the study were observed

Outcome measures

The time (mean( standard deviation)) until the onset of a burning sensation during exposure to NIR for 30 s was 20.0(8.10), 24.0(6.64), and 28.0(4.75) with test products 1, 2, and 3, respectively . The onset time with test product 3 was significantly longer than for test products 1 and 2 (1 vs. 3: p < 0.001, 2 vs. 3: p < 0.01). If the subjects did not feel a burning sensation after 30s exposure, this result was recorded as 30 s. The number of subjects who did not feel a burning sensation throughout the 30s exposure was 14, 20, and 36 for test samples 1, 2, and 3, respectively. The degree of the burning sensation after 30 s exposure to NIR was 4.27(2.85) 3.31(2.80), and 1.20(1.79) with test products 1, 2, and 3, respectively. The degree of the burning sensation with test product 3 was significantly lower than with test products 1 and 2 (1 vs. 3: p < 0.001, 2 vs. 3: p < 0.001).
The degree of the burning sensation with test products 1, 2, and 3 was 3.50(0.60), 2.32(0.57), and 0.68(0.37) in males, and 4.89(0.54), 4.11(0.52), and 1.63(0.34) in females, respectively. The time until the onset of a burning sensation with test products 1, 2, and 3 was 22.6(1.67), 25.0(1.42), and 29.4(0.99) in males, and 17.9(1.50), 23.3(1.28), and 26.9(0.89) in females, respectively.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 09 Month 09 Day

Date of IRB

2022 Year 09 Month 13 Day

Anticipated trial start date

2022 Year 09 Month 27 Day

Last follow-up date

2022 Year 09 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 10 Month 07 Day

Last modified on

2024 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055853


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name